Robert M. Patterson - 07 May 2021 Form 4 Insider Report for AVIENT CORP (AVNT)

Role
Chairman, President & CEO, Director
Signature
/s/ Lisa K. Kunkle, Power of Attorney For: Robert M. Patterson
Issuer symbol
AVNT
Transactions as of
07 May 2021
Net transactions value
-$10,817,133
Form type
4
Filing time
30 Aug 2021, 16:23:18 UTC
Next filing
15 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNT Common Stock Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities $6,365,857 -121,278 -100% $52.49 0 27 Aug 2021 Supplemental Plan F1
transaction AVNT Common Stock Gift $0 -5,000 -1.3% $0.000000 385,242 07 May 2021 Direct F2
transaction AVNT Common Stock Options Exercise $2,552,609 +66,700 +17% $38.27 451,942 27 Aug 2021 Direct
transaction AVNT Common Stock Disposed to Issuer $2,973,296 -56,645 -13% $52.49 395,297 27 Aug 2021 Direct
transaction AVNT Common Stock Options Exercise $2,627,896 +105,200 +27% $24.98 500,497 27 Aug 2021 Direct
transaction AVNT Common Stock Disposed to Issuer $3,911,450 -74,518 -15% $52.49 425,979 27 Aug 2021 Direct
transaction AVNT Common Stock Options Exercise $4,030,620 +118,200 +28% $34.10 544,179 27 Aug 2021 Direct
transaction AVNT Common Stock Disposed to Issuer $4,994,738 -95,156 -17% $52.49 449,023 27 Aug 2021 Direct
transaction AVNT Common Stock Options Exercise $2,640,494 +63,034 +14% $41.89 512,057 27 Aug 2021 Direct
transaction AVNT Common Stock Disposed to Issuer $2,936,868 -55,951 -11% $52.49 456,106 27 Aug 2021 Direct
transaction AVNT Common Stock Options Exercise $3,226,542 +102,300 +22% $31.54 558,406 27 Aug 2021 Direct
transaction AVNT Common Stock Disposed to Issuer $4,177,102 -79,579 -14% $52.49 478,827 27 Aug 2021 Direct
transaction AVNT Common Stock Options Exercise $1,810,635 +57,517 +12% $31.48 536,344 27 Aug 2021 Direct
transaction AVNT Common Stock Disposed to Issuer $2,346,618 -44,706 -8.3% $52.49 491,638 27 Aug 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVNT Stock Appreciation Rights Options Exercise $0 -66,700 -100% $0.000000* 0 27 Aug 2021 Common Stock 66,700 $38.27 Direct F4
transaction AVNT Stock Appreciation Rights Options Exercise $0 -105,200 -100% $0.000000* 0 27 Aug 2021 Common Stock 105,200 $24.98 Direct F5
transaction AVNT Stock Appreciation Rights Options Exercise $0 -118,200 -100% $0.000000* 0 27 Aug 2021 Common Stock 118,200 $34.10 Direct F6
transaction AVNT Stock Appreciation Rights Options Exercise $0 -63,034 -67% $0.000000 31,516 27 Aug 2021 Common Stock 63,034 $41.89 Direct F7
transaction AVNT Stock Appreciation Rights Options Exercise $0 -102,300 -67% $0.000000 51,150 27 Aug 2021 Common Stock 102,300 $31.54 Direct F8
transaction AVNT Stock Appreciation Rights Options Exercise $0 -57,517 -33% $0.000000 115,033 27 Aug 2021 Common Stock 57,517 $31.48 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an exempt intra-plan transfer (rule 16b-3(f)) by the reporting person of value out of the Avient stock fund and into one or more other investments under the Issuer's Supplemental Retiremet Benefit Plan pursuant to a pre-arranged trading plan.
F2 Includes shares acquired pursuant to dividend reinvestment.
F3 The listed SAR transactions were completed pursuant to a pre-arranged trading plan.
F4 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $38.27 per share and no more than one-third of the grant can vest per year during the first three years.
F5 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $24.98 per share and no more than one-third of the grant can vest per year during the first three years.
F6 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $34.10 per share and no more than one-third of the grant can vest per year during the first three years.
F7 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $41.89 per share and no more than one-third of the grant can vest per year during the first three years.
F8 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.54 per share and no more than one-third of the grant can vest per year during the first three years.
F9 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.48 per share and no more than one-third of the grant can vest per year during the first three years.